UL – Unilever plc ADR

Float Short %

0.13

Margin Of Safety %

-4

Put/Call OI Ratio

0.85

EPS Next Q Diff

EPS Last/This Y

-1.06

EPS This/Next Y

0.22

Price

65.53

Target Price

70.81

Analyst Recom

1.86

Performance Q

-6.56

Relative Volume

1.8

Beta

0.35

Ticker: UL

18 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2025-12-26	UL	66.18	0.88	0.82	45018
2025-12-29	UL	65.78	0.88	0.37	45114
2025-12-30	UL	65.64	0.87	0.36	45627
2025-12-31	UL	65.4	0.87	0.45	45731
2026-01-02	UL	65.04	0.87	2.28	45798
2026-01-05	UL	63.74	0.88	0.74	46174
2026-01-06	UL	64.48	0.88	2.21	47780
2026-01-07	UL	62.62	0.89	2.55	48523
2026-01-08	UL	63.33	0.90	0.11	49152
2026-01-09	UL	64.2	0.88	0.64	50160
2026-01-12	UL	64.43	0.87	0.25	50534
2026-01-13	UL	64.7	0.87	0.21	51024
2026-01-14	UL	65.32	0.87	0.29	51205
2026-01-15	UL	64.21	0.85	0.46	52454
2026-01-16	UL	64.51	0.85	0.31	53150
2026-01-20	UL	64.91	0.84	1.04	30845
2026-01-21	UL	64.83	0.84	1.06	31767
2026-01-22	UL	65.54	0.85	0.27	32809
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

18 items 1 of 1

18 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-12-26	UL	66.18	-	825.1	2.93
2025-12-29	UL	65.78	-	720.2	2.93
2025-12-30	UL	65.62	-	708.7	2.87
2025-12-31	UL	65.39	-	628.8	2.87
2026-01-02	UL	65.04	-	586.3	2.87
2026-01-05	UL	63.73	-	524.8	2.87
2026-01-06	UL	64.48	-	809.5	2.87
2026-01-07	UL	62.62	-	465.7	2.87
2026-01-08	UL	63.33	-	944.8	2.87
2026-01-09	UL	64.22	-	645.8	2.87
2026-01-12	UL	64.42	-	511.5	2.87
2026-01-13	UL	64.70	-	501.6	2.87
2026-01-14	UL	65.33	-	572.6	2.87
2026-01-15	UL	64.21	-	298.6	2.87
2026-01-16	UL	64.50	-	436.2	2.87
2026-01-20	UL	64.89	-	545.4	2.87
2026-01-21	UL	64.83	-	506.9	2.87
2026-01-22	UL	65.53	-	649.9	2.87
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

18 items 1 of 1

18 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-12-26	UL	0	0	0.14
2025-12-29	UL	0	0	0.14
2025-12-30	UL	0	0	0.14
2025-12-31	UL	0	0	0.14
2026-01-02	UL	0	0	0.14
2026-01-05	UL	0	0	0.14
2026-01-06	UL	0	0	0.14
2026-01-07	UL	0	0	0.14
2026-01-08	UL	0	0	0.14
2026-01-09	UL	0	0	0.14
2026-01-12	UL	0	-22.77	0.14
2026-01-13	UL	0	-22.77	0.13
2026-01-14	UL	0	-22.77	0.13
2026-01-15	UL	0	-22.77	0.13
2026-01-16	UL	0	-22.77	0.13
2026-01-20	UL	0	-22.67	0.13
2026-01-21	UL	0	-22.67	0.13
2026-01-22	UL	0	-22.67	0.13
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

18 items 1 of 1

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

-22.67

Beta

0.35

Average Sales Estimate Current Quarter

12440

Average Sales Estimate Next Quarter

12344

Fair Value

63.13

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

11.6

Max Drawdown 5-Year %

-26.6

Target Price

70.81

P/E

23.92

Forward P/E

17.72

PEG

2.86

P/S

2.2

P/B

6.84

P/Free Cash Flow

21.23

EPS

2.74

Average EPS Est. Cur. Y

2.87

EPS Next Y. (Est.)

3.09

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

9.3

Relative Volume

1.8

Return on Equity vs Sector %

6.2

Return on Equity vs Industry %

5.6

EPS 1 7Days Diff

-0.5

EPS 1 30Days Diff

-0.5

EBIT Estimation

649.9

Unilever PLC

Sector: Consumer Defensive

Industry: Household & Personal Products

Employees: 115964

Unilever PLC operates as a fast-moving consumer goods company in the Asia Pacific, Africa, the Americas, and Europe. It operates through Beauty & Wellbeing, Personal Care, Home Care, and Foods segments. The Beauty & Wellbeing segment engages in the sale of hair care products, such as shampoo, conditioner, and styling; skin care products, including face, hand, and body moisturizers; and Prestige beauty and wellbeing products. The Personal Care segment offers skin cleansing products comprising soaps and showers; deodorants; and oral care products consisting of toothpaste, toothbrush, and mouthwash products. The Home Care segment is involved in the sale of fabric care products, including washing powders and liquids, and rinse conditioners; and fabric enhancers, and home and hygiene cleaning products. The Foods segment provides cooking aids and mini meals, such as soups, bouillons, and seasonings, as well as condiments, mayonnaise and ketchup, and food solutions. The company provides its products under the AXE, Ben & Jerry's, Clear, Cif, Closeup, Comfort, Cornetto, Dermalogica, Domestos, Dove, Dove Men+Care, Hellmann's, Horlicks, Knorr, LUX, Lifebuoy, Liquid I.V., Nutrafol, OMO, Pond's, Paula's Choice, Pepsodent, Rexona, Sunlight, Sunsilk, Surf, TRESemmé, Vaseline, Wall's, and Yasso brand names. Unilever PLC was founded in 1860 and is headquartered in London, the United Kingdom.

stock quote shares UL – Unilever plc ADR Stock Price stock today

news today UL – Unilever plc ADR stock forecast ,stock prediction 2023 2024 2025

marketwatch UL – Unilever plc ADR yahoo finance google finance

stock history UL – Unilever plc ADR invest stock market

stock prices UL premarket after hours

ticker UL fair value insiders trading

UG – United-Guardian, Inc.

Float Short %

0.23

Margin Of Safety %

-9

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

6.6

Target Price

Analyst Recom

Performance Q

-13.73

Relative Volume

0.66

Beta

Ticker: UG

18 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2025-12-26	UG	6.18	N/A	N/A	0
2025-12-29	UG	6.1	N/A	N/A	0
2025-12-30	UG	6.18	N/A	N/A	0
2025-12-31	UG	6.1401	N/A	N/A	0
2026-01-02	UG	6.19	N/A	N/A	0
2026-01-05	UG	6.15	N/A	N/A	0
2026-01-06	UG	6.2	N/A	N/A	0
2026-01-07	UG	6.16	N/A	N/A	0
2026-01-08	UG	6.23	N/A	N/A	0
2026-01-09	UG	6.25	N/A	N/A	0
2026-01-12	UG	6.21	N/A	N/A	0
2026-01-13	UG	6.16	N/A	N/A	0
2026-01-14	UG	6.26	N/A	N/A	0
2026-01-15	UG	6.36	N/A	N/A	0
2026-01-16	UG	6.55	N/A	N/A	0
2026-01-20	UG	6.43	N/A	N/A	0
2026-01-21	UG	6.6	N/A	N/A	0
2026-01-22	UG	6.57	N/A	N/A	0
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

18 items 1 of 1

18 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-12-26	UG	6.10	-	-	-
2025-12-29	UG	6.12	-	-	-
2025-12-30	UG	6.14	-	-	-
2025-12-31	UG	6.16	-	-	-
2026-01-02	UG	6.16	-	-	-
2026-01-05	UG	6.14	-	-	-
2026-01-06	UG	6.23	-	-	-
2026-01-07	UG	6.20	-	-	-
2026-01-08	UG	6.24	-	-	-
2026-01-09	UG	6.22	-	-	-
2026-01-12	UG	6.23	-	-	-
2026-01-13	UG	6.22	-	-	-
2026-01-14	UG	6.27	-	-	-
2026-01-15	UG	6.35	-	-	-
2026-01-16	UG	6.73	-	-	-
2026-01-20	UG	6.49	-	-	-
2026-01-21	UG	6.60	-	-	-
2026-01-22	UG	6.60	-	-	-
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

18 items 1 of 1

18 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-12-26	UG	0.00	-2.31	0.23
2025-12-29	UG	0.00	-2.31	0.23
2025-12-30	UG	0.00	-2.31	0.23
2025-12-31	UG	0.00	-2.31	0.23
2026-01-02	UG	0.00	-2.31	0.23
2026-01-05	UG	0.00	-2.31	0.23
2026-01-06	UG	0.00	-2.31	0.23
2026-01-07	UG	0.00	-2.31	0.23
2026-01-08	UG	0.00	-2.31	0.23
2026-01-09	UG	0.00	-2.31	0.23
2026-01-12	UG	0.00	-2.30	0.23
2026-01-13	UG	0.00	-2.30	0.23
2026-01-14	UG	0.00	-2.30	0.23
2026-01-15	UG	0.00	-2.30	0.23
2026-01-16	UG	0.00	-2.30	0.23
2026-01-20	UG	0.00	-2.25	0.23
2026-01-21	UG	0.00	-2.25	0.23
2026-01-22	UG	0.00	-2.25	0.23
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

18 items 1 of 1

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

-2.25

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

5.99

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

74.7

Max Drawdown 5-Year %

-76.1

Target Price

P/E

15.39

Forward P/E

PEG

P/S

P/B

2.85

P/Free Cash Flow

19.46

EPS

0.43

Average EPS Est. Cur. Y

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

19.48

Relative Volume

0.66

Return on Equity vs Sector %

-6.5

Return on Equity vs Industry %

-7.1

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

United-Guardian, Inc.

Sector: Consumer Defensive

Industry: Household & Personal Products

Employees: 24

United-Guardian, Inc. develops, manufactures, sells, and markets specialty cosmetic ingredients, pharmaceutical products, medical lubricants, and sexual wellness ingredients in the United States and internationally. The company offers cosmetic ingredients, including LUBRAJEL, a line of multifunctional hydrogel formulations for personal care and medical products; B-122, a powdered lubricant used in the manufacture of certain cosmetics, such as pressed powders, eyeliners, and rouges, as well as some industrial products; ORCHID COMPLEX, an oil-based extract of orchids; and LUBRASIL II SB, a special formulation of Lubrajel in which silicone oil is incorporated into a Lubrajel base. It also provides medical lubricant products for catheter lubrication, medical devices, condom lubrication, and oral care under the Lubrajel brand, including Lubrajel MG, Lubrajel MGL, Lubrajel RRCG, Lubrajel RR, Lubrajel RC, Lubrajel RA, Lubrajel Fluid, Lubrajel LC, Lubrajel BA, and Lubrajel FACO. In addition, the company offers pharmaceutical products comprising RENACIDIN, a prescription to prevent and to dissolve calcifications in urethral catheters; and CLORPACTIN WCS-90, a chlorine-based drug, which is a topical antimicrobial and is also used in urology. Further, it provides sexual wellness ingredient products, which are hydrogel formulations designed to offer sensory enhancement, lubrication, and moisturization, such as Natrajel NT, Natrajel MA, Natrajel ON, and Natrajel TE product lines. United-Guardian, Inc. was founded in 1942 and is based in Hauppauge, New York.

stock quote shares UG – United-Guardian, Inc. Stock Price stock today

news today UG – United-Guardian, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch UG – United-Guardian, Inc. yahoo finance google finance

stock history UG – United-Guardian, Inc. invest stock market

stock prices UG premarket after hours

ticker UG fair value insiders trading

UL – Unilever PLCUL –

Float Short %

0.13

Margin Of Safety %

-4

Put/Call OI Ratio

0.85

EPS Next Q Diff

EPS Last/This Y

-1.06

EPS This/Next Y

0.22

Price

65.53

Target Price

70.81

Analyst Recom

1.86

Performance Q

-6.56

Relative Volume

1.8

Beta

0.35

Ticker: UL

18 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2025-12-26	UL	66.18	0.88	0.82	45018
2025-12-29	UL	65.78	0.88	0.37	45114
2025-12-30	UL	65.64	0.87	0.36	45627
2025-12-31	UL	65.4	0.87	0.45	45731
2026-01-02	UL	65.04	0.87	2.28	45798
2026-01-05	UL	63.74	0.88	0.74	46174
2026-01-06	UL	64.48	0.88	2.21	47780
2026-01-07	UL	62.62	0.89	2.55	48523
2026-01-08	UL	63.33	0.90	0.11	49152
2026-01-09	UL	64.2	0.88	0.64	50160
2026-01-12	UL	64.43	0.87	0.25	50534
2026-01-13	UL	64.7	0.87	0.21	51024
2026-01-14	UL	65.32	0.87	0.29	51205
2026-01-15	UL	64.21	0.85	0.46	52454
2026-01-16	UL	64.51	0.85	0.31	53150
2026-01-20	UL	64.91	0.84	1.04	30845
2026-01-21	UL	64.83	0.84	1.06	31767
2026-01-22	UL	65.54	0.85	0.27	32809
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

18 items 1 of 1

18 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-12-26	UL	66.18	-	825.1	2.93
2025-12-29	UL	65.78	-	720.2	2.93
2025-12-30	UL	65.62	-	708.7	2.87
2025-12-31	UL	65.39	-	628.8	2.87
2026-01-02	UL	65.04	-	586.3	2.87
2026-01-05	UL	63.73	-	524.8	2.87
2026-01-06	UL	64.48	-	809.5	2.87
2026-01-07	UL	62.62	-	465.7	2.87
2026-01-08	UL	63.33	-	944.8	2.87
2026-01-09	UL	64.22	-	645.8	2.87
2026-01-12	UL	64.42	-	511.5	2.87
2026-01-13	UL	64.70	-	501.6	2.87
2026-01-14	UL	65.33	-	572.6	2.87
2026-01-15	UL	64.21	-	298.6	2.87
2026-01-16	UL	64.50	-	436.2	2.87
2026-01-20	UL	64.89	-	545.4	2.87
2026-01-21	UL	64.83	-	506.9	2.87
2026-01-22	UL	65.53	-	649.9	2.87
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

18 items 1 of 1

18 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-12-26	UL	0	0	0.14
2025-12-29	UL	0	0	0.14
2025-12-30	UL	0	0	0.14
2025-12-31	UL	0	0	0.14
2026-01-02	UL	0	0	0.14
2026-01-05	UL	0	0	0.14
2026-01-06	UL	0	0	0.14
2026-01-07	UL	0	0	0.14
2026-01-08	UL	0	0	0.14
2026-01-09	UL	0	0	0.14
2026-01-12	UL	0	-22.77	0.14
2026-01-13	UL	0	-22.77	0.13
2026-01-14	UL	0	-22.77	0.13
2026-01-15	UL	0	-22.77	0.13
2026-01-16	UL	0	-22.77	0.13
2026-01-20	UL	0	-22.67	0.13
2026-01-21	UL	0	-22.67	0.13
2026-01-22	UL	0	-22.67	0.13
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

18 items 1 of 1

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

-22.67

Beta

0.35

Average Sales Estimate Current Quarter

12440

Average Sales Estimate Next Quarter

12344

Fair Value

63.13

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

11.6

Max Drawdown 5-Year %

-26.6

Target Price

70.81

P/E

23.92

Forward P/E

17.72

PEG

2.86

P/S

2.2

P/B

6.84

P/Free Cash Flow

21.23

EPS

2.74

Average EPS Est. Cur. Y

2.87

EPS Next Y. (Est.)

3.09

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

9.3

Relative Volume

1.8

Return on Equity vs Sector %

6.2

Return on Equity vs Industry %

5.6

EPS 1 7Days Diff

-0.5

EPS 1 30Days Diff

-0.5

EBIT Estimation

649.9

Unilever PLC

Sector: Consumer Defensive

Industry: Household & Personal Products

Employees: 115964

stock quote shares UL – Unilever PLCUL – Stock Price stock today

news today UL – Unilever PLCUL – stock forecast ,stock prediction 2023 2024 2025

marketwatch UL – Unilever PLCUL – yahoo finance google finance

stock history UL – Unilever PLCUL – invest stock market

stock prices UL premarket after hours

ticker UL fair value insiders trading

SKIN – The Beauty Health Company

Float Short %

21.67

Margin Of Safety %

Put/Call OI Ratio

0.26

EPS Next Q Diff

0.04

EPS Last/This Y

0.39

EPS This/Next Y

-0.01

Price

1.56

Target Price

1.95

Analyst Recom

3.22

Performance Q

16.42

Relative Volume

0.59

Beta

1.15

Ticker: SKIN

18 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2025-12-26	SKIN	1.453	0.44	0.00	3446
2025-12-29	SKIN	1.43	0.44	0.00	3451
2025-12-30	SKIN	1.435	0.44	0.00	3451
2025-12-31	SKIN	1.38	0.44	0.05	3450
2026-01-02	SKIN	1.395	0.44	0.04	3440
2026-01-05	SKIN	1.415	0.44	0.00	3440
2026-01-06	SKIN	1.475	0.43	0.00	3489
2026-01-07	SKIN	1.445	0.43	0.00	3496
2026-01-08	SKIN	1.57	0.43	13.50	3496
2026-01-09	SKIN	1.465	0.44	0.00	3505
2026-01-12	SKIN	1.515	0.44	0.50	3502
2026-01-13	SKIN	1.53	0.44	6.00	3530
2026-01-14	SKIN	1.54	0.44	0.07	3546
2026-01-15	SKIN	1.55	0.44	0.36	3542
2026-01-16	SKIN	1.5	0.44	0.33	3542
2026-01-20	SKIN	1.445	0.20	0.77	2721
2026-01-21	SKIN	1.535	0.26	0.33	2902
2026-01-22	SKIN	1.555	0.26	0.00	2910
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

18 items 1 of 1

18 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-12-26	SKIN	1.46	-	-	0.16
2025-12-29	SKIN	1.44	-	-	0.16
2025-12-30	SKIN	1.43	-	-	0.16
2025-12-31	SKIN	1.38	-	-	0.16
2026-01-02	SKIN	1.40	-	-	0.16
2026-01-05	SKIN	1.42	-	-	0.16
2026-01-06	SKIN	1.48	-	-	0.16
2026-01-07	SKIN	1.45	-	-	0.16
2026-01-08	SKIN	1.57	-	-	0.16
2026-01-09	SKIN	1.46	-	-	0.16
2026-01-12	SKIN	1.51	-	-	0.16
2026-01-13	SKIN	1.54	-	-	0.16
2026-01-14	SKIN	1.54	-	-	0.16
2026-01-15	SKIN	1.55	-	-	0.16
2026-01-16	SKIN	1.50	-	-	0.16
2026-01-20	SKIN	1.44	-	-	0.16
2026-01-21	SKIN	1.54	-	-	0.16
2026-01-22	SKIN	1.56	-	-	0.16
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

18 items 1 of 1

18 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-12-26	SKIN	0.00	3.84	21.83
2025-12-29	SKIN	0.00	3.85	21.83
2025-12-30	SKIN	0.00	3.85	21.83
2025-12-31	SKIN	0.00	3.85	21.83
2026-01-02	SKIN	0.00	3.85	21.83
2026-01-05	SKIN	0.00	3.90	21.83
2026-01-06	SKIN	0.00	3.90	21.83
2026-01-07	SKIN	0.00	3.90	21.83
2026-01-08	SKIN	0.00	3.90	21.83
2026-01-09	SKIN	0.00	3.90	21.83
2026-01-12	SKIN	0.00	3.89	21.83
2026-01-13	SKIN	0.00	3.89	21.67
2026-01-14	SKIN	0.00	3.89	21.67
2026-01-15	SKIN	0.00	3.89	21.67
2026-01-16	SKIN	0.00	3.89	21.67
2026-01-20	SKIN	0.00	3.82	21.67
2026-01-21	SKIN	0.00	3.82	21.67
2026-01-22	SKIN	0.00	3.82	21.67
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

18 items 1 of 1

Last Quarter Act. EPS

-0.09

Avg. EPS Est. Current Quarter

-0.05

Avg. EPS Est. Next Quarter

-0.05

Insider Transactions

Institutional Transactions

3.82

Beta

1.15

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

1.99

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

94.8

Max Drawdown 5-Year %

Target Price

1.95

P/E

Forward P/E

PEG

P/S

0.66

P/B

3.02

P/Free Cash Flow

5.16

EPS

-0.22

Average EPS Est. Cur. Y

0.16

EPS Next Y. (Est.)

0.15

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-3.89

Relative Volume

0.59

Return on Equity vs Sector %

-42.9

Return on Equity vs Industry %

-43.5

EPS 1 7Days Diff

0.2

EPS 1 30Days Diff

0.16

EBIT Estimation

The Beauty Health Company

Sector: Consumer Defensive

Industry: Household & Personal Products

Employees: 769

The Beauty Health Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells esthetic technologies and products in the Americas, the Asia-Pacific, Europe, the Middle East, and Africa. The company's flagship product is HydraFacial, which enhances the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. It also offers Syndeo devices, which are delivery systems that are designed to connect providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling and nanoneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive peptide solutions and take home sprays for treating scalp health. In addition, it operates the MyBeautyHealth mobile application for consumers to earn loyalty points and unlock savings, log skin concerns and receive personalized treatment plans, and find and connect with Hydrafacial providers. The Beauty Health Company was founded in 1997 and is headquartered in Long Beach, California.

stock quote shares SKIN – The Beauty Health Company Stock Price stock today

news today SKIN – The Beauty Health Company stock forecast ,stock prediction 2023 2024 2025

marketwatch SKIN – The Beauty Health Company yahoo finance google finance

stock history SKIN – The Beauty Health Company invest stock market

stock prices SKIN premarket after hours

ticker SKIN fair value insiders trading

IPAR – Inter Parfums, Inc.

Float Short %

7.71

Margin Of Safety %

-23

Put/Call OI Ratio

5.12

EPS Next Q Diff

-0.91

EPS Last/This Y

-0.01

EPS This/Next Y

-0.26

Price

98.04

Target Price

106

Analyst Recom

1.5

Performance Q

-1.35

Relative Volume

1.12

Beta

1.25

Ticker: IPAR

18 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2025-12-26	IPAR	85.71	4.70	1.00	399
2025-12-29	IPAR	84.71	4.60	1.00	403
2025-12-30	IPAR	84.7	4.60	1.00	403
2025-12-31	IPAR	84.87	4.60	1.00	403
2026-01-02	IPAR	85.55	4.60	1.00	403
2026-01-05	IPAR	85.69	4.55	1.20	405
2026-01-06	IPAR	87.96	4.55	1.20	405
2026-01-07	IPAR	85.58	4.83	0.20	402
2026-01-08	IPAR	88.27	4.84	7.09	403
2026-01-09	IPAR	88.31	5.20	5.50	490
2026-01-12	IPAR	89.34	5.15	11.00	504
2026-01-13	IPAR	87.88	5.14	4.40	510
2026-01-14	IPAR	90.8	5.14	4.40	510
2026-01-15	IPAR	90.36	5.10	999.99	537
2026-01-16	IPAR	89.94	5.10	0.00	537
2026-01-20	IPAR	91.32	5.41	1.00	513
2026-01-21	IPAR	92.47	5.30	0.00	517
2026-01-22	IPAR	97.94	5.12	0.25	520
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

18 items 1 of 1

18 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-12-26	IPAR	85.71	-12.4	-	5.12
2025-12-29	IPAR	84.67	-12.4	-	5.12
2025-12-30	IPAR	84.65	-12.4	-	5.12
2025-12-31	IPAR	84.81	-12.4	-	5.12
2026-01-02	IPAR	85.46	-12.4	-	5.12
2026-01-05	IPAR	85.66	-12.4	-	5.12
2026-01-06	IPAR	87.95	-12.4	-	5.12
2026-01-07	IPAR	85.60	-12.4	-	5.12
2026-01-08	IPAR	88.27	-12.4	-	5.12
2026-01-09	IPAR	88.31	-12.4	-	5.12
2026-01-12	IPAR	89.32	-12.4	-	5.12
2026-01-13	IPAR	87.79	-12.4	-	5.12
2026-01-14	IPAR	90.76	-12.4	-	5.12
2026-01-15	IPAR	90.37	-12.4	-	5.12
2026-01-16	IPAR	89.98	-12.4	-	5.12
2026-01-20	IPAR	91.29	-12.4	-	5.12
2026-01-21	IPAR	92.46	-12.4	-	5.12
2026-01-22	IPAR	98.04	-12.4	-	5.12
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

18 items 1 of 1

18 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-12-26	IPAR	-0.18	0.32	8.04
2025-12-29	IPAR	-0.18	0.32	8.04
2025-12-30	IPAR	-0.18	0.32	8.04
2025-12-31	IPAR	-0.18	0.32	8.04
2026-01-02	IPAR	-0.18	0.32	8.04
2026-01-05	IPAR	-0.18	0.31	8.04
2026-01-06	IPAR	-0.18	0.31	8.04
2026-01-07	IPAR	-0.18	0.31	8.04
2026-01-08	IPAR	-0.18	0.31	8.04
2026-01-09	IPAR	-0.18	0.31	8.04
2026-01-12	IPAR	-0.18	0.28	8.04
2026-01-13	IPAR	-0.18	0.28	7.56
2026-01-14	IPAR	-0.18	0.28	7.56
2026-01-15	IPAR	-0.18	0.28	7.56
2026-01-16	IPAR	-0.18	0.28	7.56
2026-01-20	IPAR	-0.18	0.63	7.56
2026-01-21	IPAR	-0.18	0.63	7.56
2026-01-22	IPAR	-0.18	0.63	7.71
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

18 items 1 of 1

Last Quarter Act. EPS

2.05

Avg. EPS Est. Current Quarter

0.74

Avg. EPS Est. Next Quarter

1.14

Insider Transactions

-0.18

Institutional Transactions

0.63

Beta

1.25

Average Sales Estimate Current Quarter

366

Average Sales Estimate Next Quarter

335

Fair Value

75.16

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

39.2

Max Drawdown 5-Year %

-46.5

Target Price

106

P/E

19.13

Forward P/E

20.11

PEG

8.21

P/S

2.14

P/B

3.6

P/Free Cash Flow

17.28

EPS

5.12

Average EPS Est. Cur. Y

5.12

EPS Next Y. (Est.)

4.86

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

11.24

Relative Volume

1.12

Return on Equity vs Sector %

-6.1

Return on Equity vs Industry %

-6.7

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.09

EBIT Estimation

Interparfums, Inc.

Sector: Consumer Defensive

Industry: Household & Personal Products

Employees: 647

Interparfums, Inc., together with its subsidiaries, manufactures, markets, and distributes a range of fragrances and fragrance related products in the United States and internationally. It operates in two segments, European Based Operations and United States Based Operations. The company offers its fragrance and cosmetic products under the Boucheron, Coach, Jimmy Choo, Karl Lagerfeld, Kate Spade, Lanvin, Moncler, Montblanc, Rochas, Van Cleef & Arpels, Abercrombie & Fitch, Anna Sui, Donna Karan, DKNY, Emanual Ungaro, Ferragamo, Graff, GUESS, Hollister, MCM, Oscar de la Renta, Ungaro, and Roberto Cavalli brands, as well as French Connection, Intimate, Solférino, Tristar, and Lacoste trademarks. It sells its products to department stores, perfumeries, specialty stores, duty free shops, and domestic and international wholesalers and distributors, as well as through e-commerce sites. The company was formerly known as Jean Philippe Fragrances, Inc. and changed its name to Inter Parfums, Inc. in July 1999. Interparfums, Inc. was founded in 1982 and is headquartered in New York, New York.

stock quote shares IPAR – Inter Parfums, Inc. Stock Price stock today

news today IPAR – Inter Parfums, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch IPAR – Inter Parfums, Inc. yahoo finance google finance

stock history IPAR – Inter Parfums, Inc. invest stock market

stock prices IPAR premarket after hours

ticker IPAR fair value insiders trading

USNA – USANA Health Sciences, Inc.

Float Short %

4.74

Margin Of Safety %

Put/Call OI Ratio

1.56

EPS Next Q Diff

0.55

EPS Last/This Y

EPS This/Next Y

0.22

Price

22.51

Target Price

Analyst Recom

Performance Q

7.04

Relative Volume

0.47

Beta

0.66

Ticker: USNA

18 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2025-12-26	USNA	19.86	0.75	8.00	317
2025-12-29	USNA	19.74	0.83	999.99	335
2025-12-30	USNA	19.9	0.83	999.99	335
2025-12-31	USNA	19.61	0.84	999.99	337
2026-01-02	USNA	19.43	0.84	999.99	337
2026-01-05	USNA	19.04	0.86	999.99	340
2026-01-06	USNA	19.49	0.86	999.99	340
2026-01-07	USNA	19.58	0.89	999.99	345
2026-01-08	USNA	20.02	0.92	7.00	351
2026-01-09	USNA	19.84	0.93	3.25	356
2026-01-12	USNA	20.58	1.00	2.00	370
2026-01-13	USNA	20.31	1.01	1.67	376
2026-01-14	USNA	20.49	1.00	0.00	380
2026-01-15	USNA	21.58	0.98	999.99	383
2026-01-16	USNA	21.95	1.01	2.00	388
2026-01-20	USNA	22.01	1.69	0.00	199
2026-01-21	USNA	22.2	1.64	0.00	201
2026-01-22	USNA	22.51	1.56	1.00	205
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

18 items 1 of 1

18 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-12-26	USNA	19.84	-37.5	-	1.73
2025-12-29	USNA	19.71	-37.5	-	1.73
2025-12-30	USNA	19.91	-37.5	-	1.73
2025-12-31	USNA	19.61	-37.5	-	1.73
2026-01-02	USNA	19.40	-37.5	-	1.73
2026-01-05	USNA	19.02	-37.5	-	1.73
2026-01-06	USNA	19.49	-37.5	-	1.73
2026-01-07	USNA	19.62	-37.5	-	1.73
2026-01-08	USNA	20.01	-37.5	-	1.73
2026-01-09	USNA	19.83	-37.5	-	1.73
2026-01-12	USNA	20.60	-37.5	-	1.73
2026-01-13	USNA	20.34	-37.5	-	1.73
2026-01-14	USNA	20.53	-37.5	-	1.73
2026-01-15	USNA	21.58	-37.5	-	1.73
2026-01-16	USNA	21.93	-37.5	-	1.73
2026-01-20	USNA	21.96	-35.9	-	1.73
2026-01-21	USNA	22.26	-35.9	-	1.73
2026-01-22	USNA	22.51	-35.9	-	1.73
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

18 items 1 of 1

18 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-12-26	USNA	-0.17	1.20	5.42
2025-12-29	USNA	-0.17	1.20	5.42
2025-12-30	USNA	-0.17	1.20	5.42
2025-12-31	USNA	-0.17	1.20	5.42
2026-01-02	USNA	-0.17	1.20	5.42
2026-01-05	USNA	-0.17	1.20	5.42
2026-01-06	USNA	-0.17	1.20	5.42
2026-01-07	USNA	-0.17	1.20	5.42
2026-01-08	USNA	-0.17	1.20	5.42
2026-01-09	USNA	-0.17	1.20	5.42
2026-01-12	USNA	-0.17	0.71	5.42
2026-01-13	USNA	-0.17	0.71	4.74
2026-01-14	USNA	-0.17	0.71	4.74
2026-01-15	USNA	-0.17	0.71	4.74
2026-01-16	USNA	-0.17	0.71	4.74
2026-01-20	USNA	-0.17	-0.19	4.74
2026-01-21	USNA	-0.17	-0.19	4.74
2026-01-22	USNA	-0.17	-0.19	4.74
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

18 items 1 of 1

Last Quarter Act. EPS

-0.15

Avg. EPS Est. Current Quarter

0.4

Avg. EPS Est. Next Quarter

0.4

Insider Transactions

-0.17

Institutional Transactions

-0.19

Beta

0.66

Average Sales Estimate Current Quarter

220

Average Sales Estimate Next Quarter

237

Fair Value

25.95

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

79.1

Max Drawdown 5-Year %

-82.5

Target Price

P/E

25.29

Forward P/E

11.54

PEG

4.2

P/S

0.45

P/B

0.78

P/Free Cash Flow

22.02

EPS

0.89

Average EPS Est. Cur. Y

1.73

EPS Next Y. (Est.)

1.95

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

1.86

Relative Volume

0.47

Return on Equity vs Sector %

-21.8

Return on Equity vs Industry %

-21.8

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

USANA Health Sciences, Inc.

Sector: Consumer Defensive

Industry: Packaged Foods

Employees: 1700

USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. It operates in two segments, Direct selling and Hiya Direct-To-Consumer. The company offers USANA nutritional optimizers, including supplements for cardiovascular health, skeletal/structural health, and digestive health; Essentials/CellSentials, such as vitamin and mineral supplements for age group beginning with children 13 months of age; and food products that include meal replacement shakes, snack bars, and other related products for healthy weight management, digestive health, and energy and hydration. It also provides Celavive, a skincare regimen for various skin care types and ethnicities; and all other products comprising materials and online tools for associates to build business and marketing of products The company sells its products through retail customers, a subscription model, and direct selling, as well as online. The company has a research collaboration agreement with Beijing University of Chinese Medicine; and National Sports Training Bureau. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.

stock quote shares USNA – USANA Health Sciences, Inc. Stock Price stock today

news today USNA – USANA Health Sciences, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch USNA – USANA Health Sciences, Inc. yahoo finance google finance

stock history USNA – USANA Health Sciences, Inc. invest stock market

stock prices USNA premarket after hours

ticker USNA fair value insiders trading

No more stocks to show

UL – Unilever plc ADR

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: UL

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

UG – United-Guardian, Inc.

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: UG

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

Last Quarter Act. EPS

Average EPS Est. Cur. Y

Last Quarter Act. EPS

Average EPS Est. Cur. Y

Last Quarter Act. EPS

Average EPS Est. Cur. Y